DRI vs ELAB · P/E 22, rev $13.21B vs rev $2.0M
Darden Restaurants Inc (DRI) versus Elevai Labs, Inc. Common Stock (ELAB) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Latest reported DRI revenue for 2026-05-31 was $13.21B. Net income was $1.21B. Revenue was up 9.4% from 2025-05-25 to 2026-05-31. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. ELAB currently screens at market cap $6.5M.
Not investment advice. Open the DRI and ELAB stock pages for the full models.
Not investment advice.